Skip to main content

Table 1 Susceptibility of 20 Staphylococci isolated from breast implant infections

From: Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients

  

Range

MIC50

MIC90

%S

S. aureus (13)

ciprofloxacin

≤0.12-4

≤0.12

1

92.3

 

cotrimoxazole

≤2/38

≤2/38

≤2/38

100

 

clindamycin

≤0.25

≤0.25

≤0.25

100*

 

erythromycin

≤0.25- ≥ 8

≤0.25

≥8

76.9

 

tetracycline

≤1

≤1

≤1

100

 

rifampicin

≤0.5

≤0.5

≤0.5

100

 

linezolid

1

1

1

100

 

vancomycin

≤0.5-1

1

1

100

 

oxacillin

≤0.25-1

0.5

1

100

 

gentamicin

≤0.25-0.5

0.5

0.5

100

 

daptomycin

0.12-1

0.25

1

100

S. epidermidis (7)

ciprofloxacin

≤0.12

  

100

 

cotrimoxazole

≤2/38-4

  

85.7

 

clindamycin

≤0.25

  

100

 

erythromycin

≤0.25- ≥ 8

  

28.6

 

tetracycline

≤1

  

100

 

rifampicin

≤0.5

  

100

 

linezolid

1

  

100

 

vancomycin

1

  

100

 

oxacillin

≤0.25-4

  

71.4

 

gentamicin

≤0.25- > 16

  

71.4

 

daptomycin

0.25-0.5

  

100

  1. *Two strains showed inducible clindamycin resistance.